Lung cancer death rates in lifelong nonsmokers

1. Thun MJ, Henley SJ, Burns D, et al. Lung cancer death rates in lifelong
nonsmokers. J Natl Cancer Inst 2006;98:691–699.
2. Kuschner WG, Blanc PD. Gases and other inhalants. In: LaDou J.
Current Occupational and Environmental Medicine . 3rd Ed. Norwalk,
CT: Appleton and Lange, 2004.
3. Paris JA. Pharmacologia . 3rd Ed. London: Phillips, 1820.
4. Saupe E. Carcinoma of the lung in arsenic miners; two cases. Arch
Gewerbepathol 1930;1:582.
5. Blot WJ, Fraumeni JF Jr. Arsenical air pollution and lung cancer. Lancet
1975;2:142–144.
6. Tokudome S, Kuratsune M. A cohort study on mortality from cancer
and other causes among workers at a metal refinery. Int J Cancer
1976;17:310–317.
6a. Rencher AC, Carter MW, McKee DW. A retrospective epidemiological
study of mortality at a large western copper smelter. J Occup Med
1977;19(11):754–758.
7. Axelson O, Dahlgren E, Jansson CD, et al. Arsenic exposure and
mortality: a case-referent study from a Swedish copper smelter. Br J Ind
Med 1978;35:8–15.
8. Enterline PE, Marsh GM. Mortality studies of smelter workers. Am J
Ind Med 1980;1:251–259.
9. Wall S. Survival and mortality pattern among Swedish smelter workers.
Int J Epidemiol 1980;9:73–87.
10. Jarup L, Pershagen G, Wall S. Cumulative arsenic exposure and
lung cancer in smelter workers: a dose-response study. Am J Ind Med
1989;15:31–41.
11. Jarup L, Pershagen G. Arsenic exposure, smoking, and lung cancer
in smelter workers—a case-control study. Am J Epidemiol
1991;134:545–551.
12. Barthel E. Increased risk of lung cancer in pesticide-exposed male
agricultural workers. J Toxicol Environ Health 1981;8:1027–1040.
13. Lüchtrath H. The consequences of chronic arsenic poisoning among
Moselle wine growers: pathoanatomical investigations of postmortem
examinations performed between 1960 and 1977. J Cancer Res Clin
Oncol 1983;105:173–182.
14. Heddle R, Bryant GD. Small cell lung carcinoma and Bowen’s disease
40 years after arsenic ingestion. Chest 1983;84:776–777.
15. Guo HR, Wang NS, Hu H, et al. Cell type specificity of lung cancer
associated with arsenic ingestion. Cancer Epidemiol Biomarkers Prev
2004;13:638–643.
16. Chen CJ, Chen CW, Wu MM, et al. Cancer potential in liver, lung,
bladder, and kidney due to ingested inorganic arsenic in drinking water.
Br J Cancer 1992;66:888–892.
17. Tsuda T, Babazono A, Yamamoto E, et al. Ingested arsenic and internal
cancer: a historical cohort study followed for 33 years. Am J Epidemiol
1995;141:198–209.
18. Chiou HY, Hsueh YM, Liaw KF, et al. Incidence of internal cancers
and ingested inorganic arsenic: a seven-year follow-up study in Taiwan.
Cancer Res 1995;55:1296–1300.
19. Smith A, Goycolea M, Haque R, et al. Marked increase in bladder and
lung cancer mortality in a region of Northern Chile due to arsenic in
drinking water. Am J Epidemiol 1998;147:660–669.
20. Chen Y, Ahsan H. Cancer burden from arsenic in drinking water in
Bangladesh. Am J Public Health 2004;94:741–744.
21. Chen CL, Hsu LI, Chiou HY, et al. Ingested arsenic, cigarette smoking,
and lung cancer risk: a follow-up study in arseniasis-endemic areas
in Taiwan. JAMA 2004;292:2984–2990.
22. Chiu HF, Ho SC, Yang CY. Lung cancer mortality reduction after installation
of tap-water supply system in an arseniasis-endemic area in
Southwestern Taiwan. Lung Cancer 2004;46:265–270.
23. Enterline PE, Marsh GM, Esmen NA, et al. Some effects of cigarette
smoking, arsenic, and SO2 on mortality among U.S. copper smelter
workers. J Occup Med 1987;29:831–838.
24. Pershagen G, Wall S, Taube A, et al. On the interaction between occupational
arsenic exposure and smoking and its relationship to lung
cancer. Scand J Work Environ Health 1981;7:302–309.
25. Hertz–Picciotto I, Smith AH, Holtzman D, et al. Synergism between
occupational arsenic exposure and smoking in the induction of lung
cancer. Epidemiology 1992;3:23–31.
26. Greaves WW, Rom WN, Lyon JL, et al. Relationship between lung
cancer and distance of residence from nonferrous smelter stack effluent.
Am J Ind Med 1981;2:15–23.
27. Rom WN, Varley G, Lyon JL, et al. Lung cancer mortality
among residents living near the El Paso smelter. Br J Ind Med
1982;39:269–272.
28. Frost F, Harter L, Milham S, et al. Lung cancer among women residing
close to an arsenic emitting copper smelter. Arch Environ Health
1987;42:148–152.
29. Frank AL. The epidemiology and etiology of lung cancer. Clin Chest
Med 1982;3:219–228.
30. Wicks MJ, Archer VE, Auerbach O, et al. Arsenic exposure in a copper
smelter as related to histological type of lung cancer. Am J Ind Med
1981;2:25–31.
31. Pershagen G, Bergman F, Klominek J, et al. Histological types of
lung cancer among smelter workers exposed to arsenic. Br J Ind Med
1987;44:454–458.
32. Ishinishi N, Kodama Y, Nobutomo K, et al. Preliminary experimental
study on carcinogenicity of arsenic trioxide in rat lung. Environ Health
Perspect 1977;19:191–196.
33. Ishinishi N, Yamamoto A, Hisanaga A, et al. Tumorigenicity of
arsenic trioxide to the lung in Syrian golden hamsters by intermittent
i nstillations. Cancer Lett 1983;21:141–147.
34. Ivankovic S, Eisenbrand G, Preussmann R. Lung carcinoma induction
in BD rats after a single intratracheal instillation of an arsenic-containing
pesticide mixture formerly used in vineyards. Int J Cancer 1979;24:
786–788.
35. Soucy NV, Ihnat MA, Kamat CD, et al. Arsenic stimulates angiogenesis
and tumorigenesis in vivo. Toxicol Sci 2003;76:271–279.
36. Pershagen G, Bjorklund NE. On the pulmonary tumorigenicity
of arsenic trisulfide and calcium arsenate in hamsters. Cancer Lett
1985;27:99–104.
37. Yamamoto A, Hisanaga A, Ishinishi N. Tumorigenicity of inorganic
arsenic compounds following intratracheal instillations to the lungs of
hamsters. Int J Cancer 1987;40:220–223.
38. Dong JT, Zhou CN, Luo XM. Induction of preneoplastic lesions by
sodium arsenite in human fetal respiratory epithelia in organ culture.
Environ Res 1995;68:39–43.
39. Mass MJ, Wang L. Arsenic alters cytosine methylation patterns of the
promoter of the tumor suppressor gene p53 in human lung cells: a model
for a mechanism of carcinogenesis. Mutat Res 1997;386:263–277.
40. Evans CD, LaDow K, Schumann BL, et al. Effect of arsenic
on benzo[a]pyrene DNA adduct levels in mouse skin and lung.
Carcinogenesis 2004;25:493–497.
41. Agency for Toxic Substances and Disease Registry, U.S. Department of
Health and Human Services, Public Health Service. Toxicological Profile
for Arsenic . 2000.
42. Tweedale G. Asbestos and its lethal legacy. Nat Rev Cancer 2002;
2:311–315.
43. Merewether ER. Asbestosis and carcinoma of the lung. In: Annual
Report for the Chief Inspector of Factories for the Year 1947. London: Her
Majesty’s Stationery Office, 1949.
44. Doll R. Mortality from lung cancer in asbestos workers. Brit J Industr
Med 1955;12:81–86.
45. Selikoff IJ, Churg J, Hammond EC. Asbestos exposure and neoplasia.
JAMA 1964;188:142–146.
46. Wagner JC, Sieggs CA, Marchand P. Diffuse pleural mesotheliomas
and asbestos exposure in the Northwestern Cape Province. Br J Indust
Med 1960;17:260–271.
47. Newhouse ML, Thompson H. Mesothelioma of pleura and peritoneum
following exposure to asbestos in the London area. Br J Indust Med
1965;22:261–269.
48. Huang B, Liu B, Xu M, et al. k- ras gene mutations of asbestos
and welding-fumes related human lung cancer. Wei Sheng Yan Jiu
2000;29:7–9.
49. Wang Q, Fan J, Wang H, et al. DNA damage and activation of c- ras in
human embryo lung cells exposed to chrysotile and smoking solution.
J Environ Pathol Toxicol Oncol 2000;19:13–19.
50. Nelson HH, Christiani DC, Wiencke JK, et al. k- ras mutation and occupational
asbestos exposure in lung adenocarcinoma: asbestos-related
cancer without asbestosis. Cancer Res 1999;59:4570–4573.
51. Panduri V, Surapureddi S, Soberanes S, et al. P53 mediates amosite
asbestos-induced alveolar epithelial cell mitochondria-regulated
apoptosis. Am J Respir Cell Mol Biol 2006;34:443–452.
52. Morris GF, Notwick AR, David O, et al. Development of lung tumors
in mutant p53-expressing mice after inhalation exposure to asbestos.
Chest 2004;125:S85–S86.
53. Zhao YL, Piao CQ, Wu LJ, et al. Differentially expressed genes in
asbestos-induced tumorigenic human bronchial epithelial cells: implication
for mechanism. Carcinogenesis 2000;21:2005–2010.
54. Iwata T, Kohyama N, Yano E. Chemiluminescent detection of induced
reactive oxygen metabolite production of human polymorphonuclear
leucocytes by anthophyllite asbestos. Environ Res 2002;88:36–40.
55. Schabath MB, Spitz MR, Delclos GL, et al. Association between asbestos
exposure, cigarette smoking, myeloperoxidase (MPO) genotypes,
and lung cancer risk. Am J Ind Med 2002;42:29–37.
56. MacCorkle RA, Slattery SD, Nash DR, et al. Intracellular protein
binding to asbestos induces aneuploidy in human lung fibroblasts. Cell
Motil Cytoskeleton 2006;63:646–657.
57. Brown RC, Fleming GTA, Knight AI. Asbestos affects the in vitro
uptake and detoxification of aromatic coumpounds. Environ Health
Perspect 1983;51:315–318.
58. Gerde P, Scholander P. Adsorption of benzo(a)pyrene on to asbestos
and manmade mineral fibres in an aqueous solution and in a biological
model solution. Br J Ind Med 1988;45:682–688.
59. Lacowicz J, Bevan DR, Riemer SC. Transport of a carcinogen,
benzo[a]pyrene, from particulates to lipid bilayers: a model for the fate
of particle-adsorbed polynuclear aromatic hydrocarbons, which are retained
in the lungs. Biochem Biophys Acta 1980;629:243–258.
60. Martischnig KM, Newall DJ, Barnsley WC, et al. Unsuspected exposure
to asbestos and bronchogenic carcinoma. Br Med J 1977;1:746–749.
61. Whitwell F, Newhouse ML, Bennett DR. A study of the histological
cell types of lung cancer in workers suffering from asbestosis in the
United Kingdom. Br J Ind Med 1974;31:398–403.
62. Hein MJ, Stayner LT, Lehman E, et al. Follow-up study of chrysotile
textile workers: cohort mortality and exposure response. Occup Environ
Med 2007;64:616–625.
63. Berman DW, Crump KS, Chatfield EJ, et al. The sizes, shapes, and mineralogy
of asbestos structures that induce lung tumors or mesothelioma
in AF/HAN rats following inhalation. Risk Anal 1995;15:181–195.
64. McDonald JC, McDonald AD. Chrysotile, tremolite, and carcinogenicity.
Ann Occup Hyg 1997;41:699–705.
65. Hughes JM, Weill H. Asbestosis as a precursor of asbestos related
lung cancer: results of a prospective mortality study. Br J Ind Med
1991;48:229–233.
66. Szeszenia–Dabrowska N, Urszula W, et al. Mortality study of workers
compensated for asbestosis in Poland, 1970–1997. Int J Occup Med
Environ Health 2002;15:267–278.
67. Hammond EC, Selikoff IJ, Seidman H. Asbestos exposure, cigarette
smoking, and death rates. Ann NY Acad Sci 1979;330:473–490.
68. World Trade Organization, European Community. Report of the
Appelate Body: Measures Affecting Asbestos and Asbestos-Containing
Products . 2001. Report No. WT/DS135/AB/R.
69. International Agency for Research on Cancer (IARC). Summaries &
Evaluations. Asbestos. Vol. 2, 1973:17.
70. Kannerstein M, Churg J, McCaughey WTE. Asbestos and mesothelioma:
a review. Pathol Annu 1978;13:81–129.
71. Mancuso T. Relation of duration of employment and prior respiratory
disease among beryllium workers. Environ Res 1970;3:251–275.
72. Mancuso T. Mortality study of beryllium industry workers’ occupational
lung cancer. Environ Res 1980;21:48–55.
73. Mancuso TF, El-Attar AA. Epidemiologic study of the beryllium
industry: cohort methodology and mortality studies. J Occup Med
1969;11:422–434.
74. Steenland K, Ward E. Lung cancer incidence among patients with beryllium
disease: a cohort mortality study. J Natl Cancer Inst 1991;83:1380–1385.
75. Ward E, Okun A, Ruder A, et al. A mortality study of workers at seven
beryllium processing plants. Am J Ind Med 1992;22:885–904.
76. Sanderson WT, Ward E, Steenland K, et al. Lung cancer case-control
study of beryllium workers. Am J Ind Med 2001;39:133–144.
77. MacMahon B. The epidemiological evidence on the carcinogenicity of
beryllium in humans. J Occup Med 1994;36:15–24.
78. Hardy HL. Beryllium disease: a clinical perspective. Environ Res
1980;21:1–9.
79. Williams WJ. United Kingdom beryllium registry: mortality and autopsy
study. Environ Health Perspect 1996;104(Suppl 5):949–951.
80. Nickell–Brady C, Hahn FF, Finch GL, et al. Analysis of k- ras , p53, and
c-Raf-1 mutations in beryllium-induced rat lung tumors. Carcinogenesis
1994;15:257–262.
81. Belinsky SA, Swafford DS, Finch GL, et al. Alterations in the k- ras
and p53 genes in rat lung tumors. Environ Health Perspect 1997;105
(Suppl 4):901–906.
82. Finch GL, March TH, Hahn FF, et al. Carcinogenic responses of
transgenic heterozygous p53 knockout mice to inhaled 239PuO2 or
metallic beryllium. Toxicol Pathol 1998;26:484–491.
83. Reeves AL, Deitch D, Vorwald AJ. Beryllium carcinogenesis. I.
Inhalational exposure of rats to beryllium sulfate aerosol. Cancer Res
1967;27:439–445.
84. Belinsky SA, Snow SS, Nikula KJ, et al. Aberrant CpG island methylation
of the p16(INK4a) and estrogen receptor genes in rat lung tumors
induced by particulate carcinogens. Carcinogenesis 2002;23:335–359.
85. Agency for Toxic Substances and Disease Registry: U.S. Department of
Health and Human Services, Public Health Service. Toxicological Profile
for Beryllium . 2002.
86. van Duuren BL, Goldschmidt BM, Langseth L, et al. Alpha-haloethers:
a new type of alkylating carcinogen. Arch Environ Health 1968;16:
472–476.
87. Leong BKJ, Macfarland HN, Reese WH. Induction of lung adenomas
by chronic inhalation of bis (chloromethyl) ether. Arch Environ Health
1971;22:663–666.
88. Laskin S, Kuschner J, Drew RT, et al. Tumors of the respiratory tract
induced by inhalation of bis(chloromethyl) ether. Arch Environ Health
1971;23:135–136.
89. Albert RE, Pasternack BS, Shore RE, et al. Mortality patterns among
workers exposed to chloromethyl ethers: a preliminary report. Environ
Health Perspect 1975;11:209–214.
90. DeFonso LR, Kelton SC. Lung cancer following exposure to chloromethyl
methyl ether: An epidemiological study. Archiv Environ Health
1976;31:125–130.
91. Figueroa WG, Raszowski R, Weiss W. Lung cancer in chloromethyl
methyl ether workers. New Engl J Med 1973;228:1096–1097.
92. Lemen RA, Johnson WM, Wagoner JK, et al. Cytologic observations
and cancer incidence following exposure to BCME. Ann N Y Acad Sci
1976;271:71–80.
93. Nelson N. The chloroethers-occupational carcinogens: a summary of laboratory
and epidemiology studies. Ann N Y Acad Sci 1976;271:81–90.
94. Weiss W, Figueroa WG. The characteristics of lung cancer due to chloromethyl
ethers. J Occup Med 1976;18:623–627.
95. Weiss W, Moser RL, Auerbach O. Lung cancer in chloromethyl ether
workers. Am Rev Respir Dis 1979;120:1031–1037.
96. Weiss W. Epidemic curve of respiratory cancer due to chloromethyl
ethers. J Natl Cancer Inst 1982;69:1265–1270.
97. Maher KV, DeFonso LR. Respiratory cancer among chloromethyl
ether workers. J Natl Cancer Inst 1987;78:839–843.
98. Collingwood KW, Pasternack BS, Shore RE. An industry-wide study of
respiratory cancer in chemical workers exposed to chloromethyl ethers.
J Natl Cancer Inst 1987;78:1127–1136.
99. Weiss W, Nash D. An epidemic of lung cancer due to chloromethyl
ethers. J Occup Environ Med 1997;39:1003–1009.
100. Agency for Toxic Substances and Disease Registry: U.S. Department of
Health and Human Services, Public Health Service. Toxicological Profile
for Bis(chloromethyl) Ether . 1989.
101. Machle W, Gregorius F. Cancer of the respiratory system in the
United States chromate-producing industry. Public Health Reports
1948;63:114–127.
102. Baetjer AM. Pulmonary carcinoma in chromate workers: II. Incidence of
basis of hospital records. A M A Arch Ind Hyg Occup Med 1950;2:505–516.
103. Mancuso TF, Hueper WC. Occupational cancer and other health
hazards in a chromate plant: a medical appraisal. I. Lung cancers in
chromate workers. Ind Med Surg 1951;20:358–363.
104. Bidstrup PL, Case RAM. Carcinoma of the lung in workmen in the
bichromates-producing industry in Great Britain. Brit J Industr Med
1956;13:260–264.
105. Taylor FH. The relationship of mortality and duration of employment
as reflected by a cohort of chromate workers. Am J Public Health
Nations Health 1966;56:218–229.
106. Enterline P. Respiratory cancer among chromate workers. J Occup Med
1974;16:523–536.
107. Langård S, Norseth T. A cohort study of bronchial carcinomas in workers
producing chromate pigments. Br J Ind Med 1975;32:62–65.
108. Hayes RB, Lilienfeld AM, Snell LM. Mortality in chromium
chemical production workers: a prospective study. Int J Epidemiol
1979;8:365–374.
109. Dalager NA, Mason TJ, Fraumeni JF Jr, et al. Cancer mortality
among workers exposed to zinc chromate paints. J Occup Med
1980;22:25–29.
110. Sheffet A, Thind I, Miller AM, et al. Cancer mortality in a pigment
plant utilizing lead and zinc chromates. Arch Environ Health
1982;37:44–52.
111. Langard S, Vigander T. Occurrence of lung cancer in workers producing
chromium pigments. Br J Ind Med 1983;40:71–74.
112. Hayes RB, Sheffet A, Spirtas R. Cancer mortality among a cohort of
chromium pigment workers. Am J Ind Med 1989;16:127–133.
113. Rosenman KD, Stanbury M. Risk of lung cancer among former chromium
smelter workers. Am J Ind Med 1996;29:491–500.
114. Rafnsson V, Gunnarsdottir H, Kiilunen M. Risk of lung cancer among
masons in Iceland. Occup Environ Med 1997;54:184–188.
115. Rafnsson V, Johannesdottir SG. Mortality among masons in Iceland.
Br J Ind Med 1986;43:522–525.
116. Franchini I, Magnani F, Mutti A. Mortality experience among
chromeplating workers. Initial findings. Scand J Work Environ Health
1983;9:247–252.
117. Sorahan T, Burges D, Hamilton L, et al. Lung cancer mortality
in nickel/chromium platers, 1946–1995. Occup Environ Med
1998;55:236–242.
118. Sorahan T, Harrington JM. Lung cancer in Yorkshire chrome platers,
1972–97. Occup Environ Med 2000;57:385–389.
119. Moulin JJ, Wild P, Mantout B, et al. Mortality from lung cancer and
cardiovascular diseases among stainless-steel producing workers. Cancer
Causes Control 1993;4:75–81.
120. Proctor DM, Otani JM, Finley BL, et al. Is hexavalent chromium carcinogenic
via ingestion? A weight-of-evidence review. J Toxicol Environ
Health A 2002;65:701–746.
121. Fryzek JP, Mumma MT, McLaughlin JK, et al. Cancer mortality in
relation to environmental chromium exposure. J Occup Environ Med
2001;43:635–640.
122. Levy LS, Martin PA, Bidstrup PL. Investigation of the potential
carcinogenicity of a range of chromium containing materials on rat
lung. Br J Ind Med 1986;43:243–256.
123. Cheng L, Sonntag DM, de Boer J, et al. Chromium (VI)-induced
mutagenesis in the lungs of big blue transgenic mice. J Environ Pathol
Toxicol Oncol 2000;19:239–249.
124. Hodges NJ, Adam B, Lee AJ, et al. Induction of DNA-strand breaks in
human peripheral blood lymphocytes and A549 lung cells by sodium
dichromate: association with 8-oxo-2-deoxyguanosine formation and
inter-individual variability. Mutagenesis 2001; 16:467–474.
125. Hodges NJ, Chipman JK. Down-regulation of the DNA-repair endonuclease
8-oxo-guanine DNA glycosylase 1 (hOGG1) by sodium dichromate
in cultured human A549 lung carcinoma cells. Carcinogenesis
2002;23:55–60.
126. Feng Z, Hu W, Rom WN, et al. Chromium (VI) exposure enhances
polycyclic aromatic hydrocarbon-DNA binding at the p53 gene in
human lung cells. Carcinogenesis 2003;24:771–778.
127. Paddle GM. Meta-analysis as an epidemiological tool and its application
to studies of chromium. Reg Toxicol Pharmacol 1997;26:S42–S50.
128. IARC. Chromium and chromium compounds: Chromium[VI] (Group
1) Metallic chromium and chromium[III] compounds (Group 3).
International Agency for Research on Cancer: Summaries & Evaluations.
1990;49:49.
129. Kapil V. (Agency for Toxic Substances and Disease Registry: U.S.
Department of Health and Human Services, Division of Health
Education and Promotion). Case Studies in Environmental Medicine:
Chromium Toxicity . 1992. October 1992. Report No.: ATSDR-HECS-
2001-0005.
130. Wichmann HE. Diesel exhaust particles. Inhal Toxicol 2007;19(Suppl
1):241–244.
131. Kotin P, Falk H, Thomas M. Aromatic hydrocarbons. III. Presence in
the particulate phase of diesel engine exhausts and the carcinogenicity
of exhaust extracts. Arch Ind Health 1955;11:113–120.
132. Huisingh J, Bradow R, Jungers R, et al. Application of bioassay to the
characterization of diesel particle emissions. In: Application of shortterm
bioassays in the fractionation and analysis of complex environmental
mixtures: [proceedings of a symposium; February; Williamsburg,
VA]. In: Waters M, Nesnow S, Huisingh JL, et al., eds. Environmental
Science Research. New York: Plenum Press, 1978.
133. Siak JS, Chan TL, Lees PS. Diesel particulate extracts in bacterial test
systems. Environ Int 1981;5:243–248.
134. Claxton L. Mutagenic and carcinogenic potency of diesel and related environmental
emissions: Salmonella bioassay. Environ Int 1981;5:389–391.
135. Crebelli R, Conti L, Crochi B, et al. The effect of fuel composition
on the mutagenicity of diesel engine exhaust. Mutat Res
1995;346:167–172.
136. Mitchell AD, Evans EL, Jotz MM, et al. Mutagenic and carcinogenic
potency of extracts of diesel and related environmental emissions: in
vitro mutagenesis and DNA damage. Environ Int 1981;5:393–401.
137. Brooks A, Li A, Dutcher JS, et al. A comparison of genotoxicity of automobile
exhaust particles from laboratory and environmental sources.
Environ Mutagen 1984;6:651–668.
138. Garshick E, Schenker MB, Munoz A, et al. A case-control study of lung
cancer and diesel exhaust exposure in railroad workers. Am Rev Respir
Dis 1987;135:1242–1248.
139. Garshick E, Laden F, Hart JE, et al. Lung cancer in railroad workers exposed
to diesel exhaust. Environ Health Perspect 2004;112:1539–1543.
140. Swanson GM, Lin CS, Curns PB. Diversity in the association between
occupation and lung cancer among black and white men. Cancer
Epidemiol Biomarkers Prev 1993;2:313–320.
141. Jarvholm B, Silverman D. Lung cancer in heavy equipment operators
and truck drivers with diesel exhaust exposure in the construction industry.
Occup Environ Med 2003;60:516–520.
142. Brüske–Hohlfeld I, Mohner M, Ahrens W, et al. Lung cancer risk
in male workers occupationally exposed to diesel motor emissions in
Germany. Am J Ind Med 1999;36:405–414.
143. Office of Transportation and Air Quality: U.S. Environmental Protection
Agency. Health Assessment Document for Diesel Engine Exhaust . 2002.
EPA/600/8-90/057F.
144. Occupational Safety & Health Administration. Safety and Health
Topics: Diesel Exhaust . 2003. 09 July 2003.
144a. Graham Jones J. An investigation into the effects of exposure to an
oil mist on workers in a mill for the cold reduction of steel strip. Ann
Occup Hyg 1961;3:264–271.
145. Hazard of mineral-oil mist? Lancet 1970;2:967–968.
146. Bryan CS, Boitnott JK. Adenocarcinoma of the lung with chronic mineral
oil pneumonia. Am Rev Respir Dis 1969;99:272–274.
147. Holmes JG, Kipling MD, Waterhouse JA. Subsequent malignancies in
men with scrotal epithelioma. Lancet 1970;2:214–215.
148. Järvholm B. Mortality and cancer morbidity in workers exposed to cutting
fluids. Archiv Environ Health 1987;42:361–366.
149. Leon DA, Thomas P, Hutchings S. Lung cancer among newspaper
printers exposed to ink mist: a study of trade union members in
Manchester, England. Occup Environ Med 1994;51:87–94.
150. Zhao Y, Krishnadasan A, Kennedy N, et al. Estimated effects of solvents
and mineral oils on cancer incidence and mortality in a cohort of
aerospace workers. Am J Ind Med 2005;48:249–258.
151. Tolbert PE. Oils and cancer. Cancer Causes and Control 1997;8:386–405.
152. Occupational Safety and Health Administration. Occupational Safety and
Health Guideline for Oil Mist: Mineral Oil . Washington D.C., 1996.
153. Doll R. Cancer of the lung and nose in nickel workers. Br J Ind Med
1958;15:217–223.
154. Doll R, Matthews JD, Morgan LG. Cancers of the lung and nasal sinuses
in nickel workers: a reassessment of the period of risk. Br J Ind
Med 1977;34:102–105.
155. Enterline PE, Marsh GM. Mortality among workers in a nickel refinery
and alloy manufacturing plant in West Virginia. J Natl Cancer Inst
1982;68:925–933.
156. Shannon HS, Julian JA, Roberts RS. Mortality study of 11,500 nickel
workers. J Natl Cancer Inst 1984;73:1251–1258.
157. International Committee on Nickel Carcinogenesis in Man. Report of
the International Committee on Nickel Carcinogenesis in Man. Scand
J Work Environ Health 1990;16:1–82.
158. Grimsrud TK, Berge SR, Haldorsen T, et al. Exposure to different
forms of nickel and risk of lung cancer. Am J Epidemiol
2002;156:1123–1132.
159. Grimsrud TK, Berge SR, Martinsen JI, et al. Lung cancer incidence
among Norwegian nickel-refinery workers 1953–2000. J Environ
Monit 2003;5:190–197.
160. Grimsrud TK, Peto J. Persisting risk of nickel related lung cancer
and nasal cancer among Clydach refiners. Occup Environ Med
2006;63:365–366.
161. Sorahan T. Mortality of workers at a plant manufacturing nickel alloys,
1958–2000. Occup Med (Lond) 2004;54:28–34.
162. Sorahan T, Williams SP. Mortality of workers at a nickel carbonyl refinery,
1958–2000. Occup Environ Med 2005;62:80–85.
163. Magnus K, Anderson A, Hogetveit AC. Cancer of respiratory organs
among workers at a nickel refinery in Norway, second report. Int J
Cancer 1982;30:681–685.
164. Ottolenghi AD, Haseman JK, Payne WW, et al. Inhalation studies of
nickel sulfide in pulmonary carcinogenesis of rats. J Natl Cancer Inst
1975;54:1165–1172.
165. Dunnick JK, Elwell MR, Radovsky AE, et al. Comparative
carcinogenic effects of nickel subsulfide, nickel oxide, or nickel
sulfate hexahydrate chronic exposures in the lung. Cancer Res
1995;55:5251–5256.
166. National Toxicology Program. NTP Toxicology and Carcinogenesis
Studies of Nickel Subsulfide (CAS No. 12035-72-2) in F344 Rats and
B6C3F1 Mice (Inhalation Studies). Natl Toxicol Program Tech Rep Ser
1996;453:1–365.
167. Pott F, Ziem U, Reiffer FJ, et al. Carcinogenicity studies on fibres, metal
compounds, and some other dusts in rats. Exp Pathol 1987;32:129–152.
168. Maehle L, Metcalf RA, Ryberg D, et al. Altered p53 gene structure and
expression in human epithelial cells after exposure to nickel. Cancer Res
1992;52:218–221.
169. Dally H, Hartwig A. Induction and repair inhibition of oxidative
DNA damage by nickel (II) and cadmium (II) in mammalian cells.
Carcinogenesis 1997;18:1021–1026.
170. Agency for Toxic Substances and Disease Registry: U.S. Department of
Health and Human Services, Public Health Service. Toxicological Profile
for Nickel . 1997.
171. Elkind MM. Enhanced tumorigenesis by small, protracted doses of
densely ionizing radiation. Chin Med J 1994;107:414–419.
172. Tierney LA, Hahn FF, Lechner JF. P53, erB -2, and K- ras gene alterations
are rare in spontaneous and plutonium-239-induced canine lung
neoplasia. Radiat Res 1996;145:181–187.
173. Hei TK, Wu LJ, Liu SX, et al. Mutagenic effects of a single and an exact
number of alpha particles in mammalian cells. Proc Natl Acad Sci U S A
1997;94:3765–3770.
174. Bignon J, Monchaux G, Chameaud J, et al. Incidence of various types
of thoracic malignancy induced in rats by intrapleural injection of
2 mg of various mineral dusts after inhalation of 222Ra. Carcinogenesis
1983;4:621–628.
175. Lafuma J, Chmelevsky D, Chameaud J, et al. Lung carcinomas in
Sprague–Dawley rats after exposure to low doses of radon daughters,
fission neutrons, or gamma rays. Radiat Res 1989;118:230–245.
176. Groch KM, Khan MA, Brooks AL, et al. Lung cancer response following
inhaled radon in the A/J and C57BL/6J mouse. Int J Radiat Biol
1997;71:301–308.
177. Lorenz E. Radioactivity and lung cancer: a critical review of lung cancer
in the miners of Schneeberg and Joachimsthal. J Natl Cancer Inst
1944;5:1–15.
178. Advisory Committee on Human Radiation Experiments: U.S.
Government Printing Office. Final Report: Advisory Committee on
Human Radiation Experiments . 1995.
179. Donaldson AW. The epidemiology of lung cancer among uranium
miners. Health Physics 1969;16:563–569.
180. Holaday DA, Doyle HN. Environmental studies in the uranium mines,
radiological health, and safety in mining and milling of nuclear materials.
Vienna: International Atomic Energy Agency. 1964;1:9–20.
181. Archer VE, Wagoner JK, Lundin FE. Lung cancer among uranium
miners in the United States. Health Physics 1973;25:351–371.
182. Brugge D, Goble R. The history of uranium mining and the Navajo
people. Am J Pub Health 2002;92:1410–1419.
183. Archer VE, Gillam JD, Wagoner JK. Respiratory disease mortality
among uranium miners. Ann NY Acad Sci 1976;271:280–293.
184. Gottlieb LS, Husen LA. Lung cancer among Navajo uranium miners.
Chest 1982;81:449–452.
185. Samet JM, Kutvirt DM, Waxweiler RJ, et al. Uranium mining and
lung cancer in Navajo men. New Engl J Med 1984;310:1481–1484.
186. Radford E, St Clair Renard KG. Lung cancer in Swedish iron miners exposed
to low doses of radon daughters. New Engl J Med 1984;310:1485–1494.
187. Harley NH. Radon and lung cancer in mines and homes. N Engl J Med
1984;310:1525–1527.
188. National Council on Radiation Protection and Measurements.
Exposures from the Uranium Series with Emphasis on Radon and Its
Daughters . 1984; NCRP Report No. 77.
189. Lubin JH, Wang ZY, Boice JD Jr, et al. Risk of lung cancer and residential
radon in China: pooled results of two studies. Int J Cancer
2004;109:132–137.
190. Darby S, Hill D, Auvinen A, et al. Radon in homes and risk of lung
cancer: collaborative analysis of individual data from 13 European casecontrol
studies. BMJ 2005;330:223.
191. Krewski D, Lubin JH, Zielinski JM, et al. Residential radon and risk
of lung cancer: a combined analysis of 7 North American case-control
studies. Epidemiology 2005;16:137–145.
192. Wagner MMF, Wagner JC. Lymphomas in the Wistar rat after intrapleural
inoculation of silica. J Natl Cancer Inst 1972;49:81–91.
193. Wagner MMF. Pathogenesis of malignant histiocytic lymphoma induced
by silica in a colony of specific-pathogen-free Wistar rats. J Natl
Cancer Inst 1976;57:509–518.
194. Wagner MM, Wagner JC, Davies R, et al. Silica-induced malignant
histiocytic lymphoma: Incidence linked with strain of rat and type of
silica. Br J Cancer 1980;41:908–917.
195. Stenbäck F, Rowland J. Experimental respiratory carcinogenesis in
hamsters: environmental, physicochemical, and biological aspects.
Oncology 1979;36:63–71.
196. Holland LM, Gonzales M, Wilson JS, et al. Pulmonary effects of shale
dusts in experimental animals. In: Wagner WL, Rom WN, Merchant
JA, Eds. Health Issues Related to Metal and Nonmetallic Mining. Boston,
MA: Butterworth Publishers, 1983:485–496.
197. Holland LM, Wilson JS, Tillery MI, et al. Lung cancer in rats exposed
to fibrogenic dusts. In: Goldsmith DF, Winn DM, Shy CM, Eds. Silica,
Silicosis, and Cancer: Controversy in Occupational Medicine (Cancer
Research Monographs. Vol. 2). New York: Praeger, 1986:267–279.
198. Thiele A, Rostoski O, Saupe E, et al. Ueber den Schneeberger
Lungenkrebs. München Med Wchnschr 1924;71:24–25.
199. Milham S Jr. Cancer mortality pattern associated with exposure to metals.
Ann N Y Acad Sci. 1976;271:243–249.
200. Westerholm P. Silicosis: observation on a case register. Scand J Work
Environ Health 1980;6(Suppl 2):1–86.
201. Ulm K, Gerein P, Eigenthaler J, et al. Silica, silicosis, and lung cancer:
results from a cohort study in the stone and quarry industry. Int Arch
Occup Environ Health 2004;77:313–318.
202. Kurihara N, Wada O. Silicosis and smoking strongly increase lung cancer
risk in silica-exposed workers. Ind Health 2004;42:303–314.
203. Marinaccio A, Scarselli A, Gorini G, et al. Retrospective mortality cohort
study of Italian workers compensated for silicosis. Occup Environ
Med 2006;63:762–765.
204. Finkelstein M, Kusiak R, Suranyi G. Mortality among miners receiving
workmen’s compensation for silicosis in Ontario, 1940–1975. J Occup
Med 1982;24:663–667.
205. Attfield MD, Costello J. Quantitative exposure response for silica
dust and lung cancer in Vermont granite workers. Am J Ind Med
2004;45:129–138.
206. Heppleston AG. Silica, pneumoconiosis, and carcinoma of the lung.
Am J Ind Med 1985;7:285–294.
207. Chen W, Bochmann F, Sun Y. Effects of work related confounders on
the association between silica exposure and lung cancer: a nested casecontrol
study among Chinese miners and pottery workers. Int Arch
Occup Environ Health 2007;80:320–326.
208. Becker BJP, Chatgidakis CB. The heart in silicosis.In: Proc Int Conf on
Silicosis. Johannesburg: Churchill, 1959.
209. Rüttner JR. Kann der silikose eine ätiologische Bedeutung für die
Geschwulstbildung zugesprochen warden? Oncologia 1949;2:115–122.
210. Chatgidakis CB. Silicosis in South African white gold miners. S African
J Adv Med Sci 1963;9:383–392.
211. Checkoway H, Hughes JM, Weill H, et al. Crystalline silica exposure,
radiological silicosis, and lung cancer mortality in diatomaceous earth
industry workers. Thorax 1999;54:56–59.
212. Checkoway H, Franzblau A. Is silicosis required for silica-associated
lung cancer. Am J Ind Med 2000;37:252–259.
213. McDonald JC, McDonald AD, Hughes JM, et al. Mortality from
lung and kidney disease in a cohort of North American industrial sand
workers: an update. Ann Occup Hyg 2005;49:367–373.
214. Agency for Toxic Substances and Disease Registry: U.S. Department of
Health and Human Services, Public Health Service. Toxicological Profile
for Synthetic Vitreous Fibers . 2002.
215. Kielhorn J, Melber C, Wahnschaffe U, et al. Vinyl chloride: still a cause
for concern. Environ Health Perspect 2000;108:579–588.
216. Viola PL, Bigotti A, Caputo A. Oncogenic response of rat skin, lungs,
and bones to vinyl chloride. Cancer Res 1971;31:516–522.
217. Creech JL Jr, Johnson MN. Angiosarcoma of liver in the manufacture
of polyvinyl chloride. J Occup Med 1974;16:150–151.
218. Tabershaw IR, Gaffey WR. Mortality study of workers in the manufacture
of vinyl chloride and its polymers. J Occup Med 1974;16:509–518.
219. Waxweiler RJ, Stringer W, Wagoner JK, et al. Neoplastic risk among
workers exposed to vinyl chloride. Ann N Y Acad Sci 1976;271:
40–48.
220. Heath CW Jr, Falk H, Creech JL Jr. Characteristics of cases of angiosarcoma
of the liver among vinyl chloride workers in the United States.
Ann N Y Acad Sci 1975;246:231–236.
221. Duck BW, Carter JT, Coombes EJ. Mortality study of workers in a
polyvinyl-chloride production plant. Lancet 1975;2:1197–1199.
222. Boffetta P, Matisane L, Mundt KA, et al. Meta-analysis of studies of
occupational exposure to vinyl chloride in relation to cancer mortality.
Scand J Work Environ Health 2003;29:220–229.
223. Agency for Toxic Substances and Disease Registry: U.S. Department of
Health and Human Services, Public Health Service. Toxicological Profile
for Vinyl Chloride . 1997.